Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

LUBASH BARBARA N — Flexion Therapeutics Inc insider: 2 transactions · InsiderLens

Home / Insiders / LUBASH BARBARA N

LUBASH BARBARA N

Former 10% Holder at Alexza Pharmaceuticals Inc. · on record since Mar 14, 2006
10% owner at Alexza Pharmaceuticals Inc. · on record since Mar 8, 2006
10% owner at NOVACEA INC · on record since May 15, 2006
10% owner at HELICOS BIOSCIENCES CORP · on record since May 24, 2007
Former 10% Owner at INSULET CORP · on record since May 17, 2007
10% owner at INSULET CORP · on record since May 14, 2007
Director at Flexion Therapeutics Inc · on record since Sep 12, 2014
10% owner at Flexion Therapeutics Inc · on record since Sep 12, 2014
10% owner at INTROGEN THERAPEUTICS INC · on record since Sep 12, 2014
10% owner at GENOMIC HEALTH INC · on record since Sep 28, 2005
10% owner at Vivani Medical, Inc. · on record since Nov 18, 2014
10% owner at GLAUKOS Corp · on record since Jun 30, 2015
10% owner at INTRALASE CORP · on record since Oct 6, 2004
10% owner at PHASERX, INC. · on record since May 24, 2016
former 10% owner at GLAUKOS Corp · on record since Jun 2, 2016

Insider trading activity of LUBASH BARBARA N

Transactions on record: 2; since Jun 10, 2016

Open-market buys: 2; $10M

Open-market sells: 0

Companies traded: 1; last filing Jun 10, 2016

Figures computed from official regulatory filings — methodology.

Companies where LUBASH BARBARA N has traded

Flexion Therapeutics Inc2 tx · $10M · Jun 10, 2016

Track record of LUBASH BARBARA N

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of LUBASH BARBARA N

Co-insiders of LUBASH BARBARA N

ATWOOD BRIAN GAlexza Pharmaceuticals Inc. +10
COLELLA SAMUEL DAlexza Pharmaceuticals Inc. +10
JAFFE ROSS A MDAlexza Pharmaceuticals Inc. +10
LINK WILLIAM J PHDAlexza Pharmaceuticals Inc. +10
MILDER DONALD BAlexza Pharmaceuticals Inc. +10
ROBERTSON REBECCA BAlexza Pharmaceuticals Inc. +10
Bolzon Bradley J PhDAlexza Pharmaceuticals Inc. +6

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Warden Charles MAlexza Pharmaceuticals Inc. +6

Versant Affiliates Fund II-A, LPAlexza Pharmaceuticals Inc. +4

Versant Side Fund II, LPAlexza Pharmaceuticals Inc. +4

Versant Venture Capital II, LPAlexza Pharmaceuticals Inc. +4

Versant Ventures II LLCAlexza Pharmaceuticals Inc. +4

VERSANT AFFILIATES FUND I-A LPGENOMIC HEALTH INC +3

VERSANT AFFILIATES FUND I-B LPGENOMIC HEALTH INC +3

VERSANT SIDE FUND I LPGENOMIC HEALTH INC +3

VERSANT VENTURE CAPITAL I LPGENOMIC HEALTH INC +3

VERSANT VENTURES I LLCGENOMIC HEALTH INC +3

BLAIR JAMES CGLAUKOS Corp +2

DOVEY BRIAN HGLAUKOS Corp +2

GIANOS PHILIP TGLAUKOS Corp +2

Holmes W StephenGLAUKOS Corp +2

Kliman Gilbert HGLAUKOS Corp +2

ORONSKY ARNOLD LGLAUKOS Corp +2

Samuels Camille DAlexza Pharmaceuticals Inc. +2

SCHOEMAKER KATHLEEN KGLAUKOS Corp +2

TREU JESSE IGLAUKOS Corp +2

5AM CO-INVESTORS II LPFlexion Therapeutics Inc +1

5AM Ventures II LPFlexion Therapeutics Inc +1

BRADBURY DANIELNOVACEA INC +1

CASH HARVEY BINTRALASE CORP +1

CLEVELAND BRUCE AGLAUKOS Corp +1

DOMAIN ASSOCIATESGLAUKOS Corp +1

DOMAIN PARTNERS IV LPGLAUKOS Corp +1

DP IV ASSOCIATES LPGLAUKOS Corp +1

Ehrlich Christopher BINTRALASE CORP +1

FRAZIER ALAN DAlexza Pharmaceuticals Inc. +1

Halak Brian KGLAUKOS Corp +1

InterWest Management Partners IX, LLCGLAUKOS Corp +1

InterWest Partners IX, LPGLAUKOS Corp +1

ISALY SAMUEL DGLAUKOS Corp +1

Kjellson Nina SGLAUKOS Corp +1

LORTZ W MARKINSULET CORP +1

Lukatch HeathFlexion Therapeutics Inc +1

MORE ROBERT JGLAUKOS Corp +1

Moretti August JAlexza Pharmaceuticals Inc. +1

NASR KHALEDGLAUKOS Corp +1

Novo A/SFlexion Therapeutics Inc +1

ORBIMED ADVISORS LLCGLAUKOS Corp +1

Pepper Douglas AGLAUKOS Corp +1

Praeger Robin L.Flexion Therapeutics Inc +1

Company	Filed	Type	Qty	Price	Value · USD	Src
Flexion Therapeutics Inc	Jun 10, 2016	Buy	710,091	14.00 USD	$9.9M	SEC
Flexion Therapeutics Inc	Jun 10, 2016	Buy	4,194	14.00 USD	$58.7K	SEC